Literature DB >> 16635663

The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.

Timothy G Berger1, Madeleine Duvic, Abby S Van Voorhees, Marta J VanBeek, Ilona J Frieden.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16635663     DOI： 10.1016/j.jaad.2006.01.054

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  15 in total

Review 1.  Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

2.  Update of the management of chronic psoriasis: new approaches and emerging treatment options.

Authors:  Philip M Laws; Helen S Young
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-04-21

3.  Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

Authors:  Grace K Kim; James Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

Review 4.  Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Adelaide A Hebert
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

Review 5.  Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.

Authors:  Seth J Orlow
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 6.  Topical pimecrolimus: a review of its use in the management of pediatric atopic dermatitis.

Authors:  Lily P H Yang; Monique P Curran
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 7.  A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

Authors:  Mark Lebwohl; Tara Gower
Journal:  MedGenMed       Date:  2006-10-10

8.  Update on the management of chronic eczema: new approaches and emerging treatment options.

Authors:  Hobart W Walling; Brian L Swick
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-07-28

Review 9.  Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs.

Authors:  Catharina M Lerche; Hans Christian Wulf
Journal:  Dermatol Reports       Date:  2010-09-14

Review 10.  Nonsteroidal Topical Immunomodulators in Allergology and Dermatology.

Authors:  Marina Jovanović; Zoran Golušin
Journal:  Biomed Res Int       Date:  2016-04-06       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.